Subhashree Samantaray

Subhashree Samantaray

Auto-generated profile, based on publicly available information

Subhashree Samantaray

Department of General Medicine (Infectious Diseases), All India Institute of Medical Sciences, Jodhpur, Rajasthan, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2021 in Mycoses
Verified
Journal Article
Closed access
PDF file
DMDurga Shankar Meena
Durga Shankar Meena
DKDeepak Kumar
Deepak Kumar
MAMadhulata Agarwal
Madhulata Agarwal
GBGopal Krishana Bohra
Gopal Krishana Bohra
RCRahul Choudhary
Rahul Choudhary
MGMahendra Kumar Garg
Mahendra Kumar Garg

26 March 2022 in The Journal of Applied Laboratory Medicine
Verified
Journal Article
Closed access
SSSubhashree Samantaray
Subhashree Samantaray
RSRakesh Singh
Rakesh Singh
Background: Phenotypically identified Candida parapsilosis is actually a complex of 3 member species named Candida parapsilosis sensu stricto (CPSS), Candida orthopsilosis (CO), and Candida metapsilosis (CM), which can be identified only by molecular methods and automated methods such as MALDI-TOF mass spectrometry (MS). This study was undertaken to evaluate the VITEK MS, which uses the principle of MALDI-TOF MS for the identification of member species of C. parapsilosis complex (CPC). Methods: In this cross-sectional study, 126 presumptively identified and stocked isolates of CPC were included. Definite identification to species level was done by VITEK MS and PCR as the gold standard method. Clinico-demographic characters and risk factors were analyzed. Antifungal susceptibility testing was performed for fluconazole and voriconazole. Results: Twelve isolates were not identified as CPC either by VITEK MS or PCR and hence were excluded from the analysis. Out of 114 CPC isolates, 89 (78.1%), 18 (15.8%), and 7 (6.1%) isolates were identified as CPSS, CO, and CM, respectively, by VITEK MS. PCR identified 84 (79.2%), 15 (14.2%), and 7 (6.6%) isolates as CPSS, CO, and CM, respectively. However, PCR did not detect 8 isolates of CPSS detected by VITEK MS. VITEK MS showed 95.3% agreement in species identification and showed a kappa coefficient of 0.87, which is almost perfect agreement. Predominant isolations of all 3 species were from blood. Resistance was observed more in CPSS for both the azoles. Conclusion: MALDI-TOF MS can be used as a rapid, reliable, cost-effective method to identify the species of CPC.

1 August 2022 in Infectious Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
SSSubhashree Samantaray
Subhashree Samantaray
PKPriyabrat Karan
Priyabrat Karan
ASAnuradha Sharma
Anuradha Sharma
VNVijayalakshmi Nag
Vijayalakshmi Nag
NDNaveen Dutt
Naveen Dutt
SMSanjeev Misra
Sanjeev Misra
Background: The higher mortality rate in COVID-19 patients is still a concern. Though some studies mention that elderly patients with co-morbidities are at higher risk of mortality, some others report uneventful outcomes in young patients even without co-morbidities. Secondary bacterial and fungal infections, especially with nosocomial pathogens are known to be associated with worse outcome in the ongoing pandemic as well as in the previous viral outbreaks. In such a scenario, the outcome of hospitalized COVID-19 patients can be improved by timely identification of secondary infections using appropriate biomarkers and by following appropriate infection control measures to prevent the spread of nosocomial pathogens. Objective: The study aims to find out the prevalence of bloodstream infections (BSI) among hospitalized COVID-19 patients and to analyze their laboratory markers and outcome by comparing them with those without BSI. Methods: In this descriptive cross-sectional study, the prevalence of secondary BSI was determined among the hospitalized COVID-19 patients by including 388 blood culture bottles collected from 293 patients, which were received in the microbiology lab within the study period. Results: The overall prevalence of BSI in COVID-19 patients was 39.5% (116/293), out of which 35.5% (104/293) infections were bacterial, and 4.1% (12/293) were fungal, while 8.9% (26/293) patients grew contaminants, and 51.5% (151/293) were sterile. Common causative agents of secondary BSI were found to be MDR Klebsiella pneumoniae (10.9%) and Acinetobacter baumannii (8.8%) followed by Candida species (4.1%). Patients with co-morbidities like diabetes, hypertension and COPD were at higher risk of developing BSI with significantly higher levels of sepsis markers such as Creactive protein (CRP), procalcitonin, ferritin and Interleukin-6 (IL-6). The mortality rate was significantly higher (60.2%) in patients with BSI compared to the group of patients without BSI. Conclusion: Our findings suggest the necessity of early diagnosis of the secondary infections using appropriate biomarkers and following proper infection control measures to prevent the spread of the nosocomial infections and improve the outcome of hospitalized COVID-19 patients.

1 January 2023 in Access Microbiology
Verified
Journal Article
Open access
SSShivang Sharma
Shivang Sharma
SSSubhashree Samantaray
Subhashree Samantaray
DKDeepak Kumar
Deepak Kumar
DMDurga Shankar Meena
Durga Shankar Meena
RCRahul Chaudhary
Rahul Chaudhary
MGMahendra Kumar Garg
Mahendra Kumar Garg
Fungal endocarditis is a rare and fatal condition, most frequently caused by species of the genera Candida and Aspergillus. Fever and changing heart murmur are the most common clinical manifestations. The diagnosis of fungal endocarditis is challenging, with prosthetic valve endocarditis being extremely difficult to diagnose. The optimal management of the condition still remains debatable. We present a case of prosthetic valve endocarditis caused by Candida parapsilosis, managed empirically with liposomal amphotericin B, which was later shifted to combination therapy with high-dose echinocandin and fluconazole, but had a fatal outcome because the patient could not undergo timely surgical intervention. Treating C. parapsilosis endocarditis cases is difficult because of their biofilm production on native and prosthetic heart valves. A combined approach consisting of a high index of clinical suspicion, early diagnosis using serological markers followed by culture or PCR and prompt initiation of appropriate antifungals may aid in improving outcomes.

8 December 2020 in Asia Pacific Journal of Public Health
Verified
Journal Article
Open access
PDF file
SSSubhashree Samantaray
Subhashree Samantaray
VNVijaya L. Nag
Vijaya L. Nag
PRPankaj Rawat
Pankaj Rawat
SMSanjeev Misra
Sanjeev Misra
AAAlisha Aggarwal
Alisha Aggarwal
BMBalwant Manda
Balwant Manda
The pandemic of coronavirus disease has created a global emergency after its origin in China, in December 2019. We investigated SARS-CoV-2 infection in the local population of a prime city of Western Rajasthan in India and found that the co-morbidities like diabetes (54.3%), cardiovascular diseases (28.8%), chronic respiratory conditions (18.4%) are the predominant risk factors for acquiring the infection. The young adult male population from urban area were maximum affected by the disease. Most common presenting complains were dry cough (65.7%), fever (62.3%) followed by sore throat (24.1%). A declining positive case percentage was found over the study period, though the number of samples received for SARS-CoV-2 testing increased with time, implying the effectiveness of government policies at community level to spread the outbreak.

13 September 2022
Verified
Preprint
Open access
SSShivang Sharma
Shivang Sharma
SSSubhashree Samantaray
Subhashree Samantaray
DKDeepak Kumar
Deepak Kumar
DMDurga Shankar Meena
Durga Shankar Meena
RCRahul Chaudhary
Rahul Chaudhary
MGMahendra Kumar Garg
Mahendra Kumar Garg
Fungal endocarditis is a rare and fatal condition , most frequently caused by the Candida and Aspergillus species. Fever and changing heart murmur are the most common clinical manifestations. The diagnosis of fungal endocarditis is challenging, especially that of prosthetic valve endocarditis is extremely difficult. The optimal management of the condition still remains debatable. We hereby present a case of prosthetic valve endocarditis caused by Candida parapsilosis , managed empirically with liposomal amphotericin B and later on was shifted to combination therapy with high dose echinocandin and fluconazole, but had a fatal outcome because he could not undergo timely surgical intervention. Treating Candida parapsilosis endocarditis cases are difficult because of their ability of biofilm production on native and prosthetic heart valves. A combined approach consisting of high index of clinical suspicion, early diagnosis by using serological markers followed by culture or PCR and prompt initiation of appropriate antifungals may aid in improving the outcome.